
15:20 ET ARDT ALERT: Hagens Berman Scrutinizing Suit Against Ardent Health (ARDT) Over Alleged Revenue Cycle Deception and $97M Adjustments

I'm PortAI, I can summarize articles.
Hagens Berman is investigating Ardent Health, Inc. (NYSE: ARDT) over allegations of misleading investors regarding revenue recognition and liability reserves. The firm claims Ardent's use of a '180-day cliff' for reserves inflated receivables, leading to a significant stock drop after a $54 million reserve increase was disclosed. Investors who purchased ARDT shares between July 18, 2024, and November 12, 2025, are encouraged to contact Hagens Berman, as the lead plaintiff deadline is March 9, 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

